Welcome to the website of the Society of Radiopharmaceutical Sciences!
Our primary goal for this website is to make it a useful resource for SRS members and non-members. Some content is accessible only to members through the "Members Only" page. Members should login to this page with a special password. If you do not have this password, please contact Charles Metzger [cmetzger(at)srsweb.org].
The abstract submission system opened on September 2, 2024 and will close on December 2, 2024.
The 2023 Bill Eckelman Publication Award is awarded to Maryam Oroujeni, Ekaterina A. Bezverkhniaia, Tianqi Xu, Yongsheng Liu, Evgenii V. Plotnikov, Susanne Klint, Eva Ryer, Ida Karlberg, Anna Orlova, Frederik Y. Frejd, Vladimir Tolmachev for their article.
Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3
Submit your Targeted Alpha Therapy research for the Nuclear Medicine and Biology special issue. Research and review papers are welcomed. Submission deadline: September 1, 2024
P. August (Gusti) Schubiger, Ph.D., professor emeritus at the Institute of Pharmaceutical Sciences of the ETH Zurich passed away on April 24th 2024
He leaves behind a loving family and a community of friends, colleagues and students who continue to be inspired by his life's work.
The 25th International Symposium of Radiopharmaceutical Sciences was a great success!
If you're interested in learning more about iSRS meetings, take a look at some pages from iSRS 2023 in Honolulu, Hawaii, to get a better understanding of the iSRS events!
If you have suggestions for improving this website, please let us know through the Contact page. Our Executive Director works with the Website Committee to keep improving our ability to serve our members and the Radiopharmaceutical Sciences community.
Stay up-to-date with the latest news from the Society of Radiopharmaceutical Sciences! Follow us on LinkedIn, Facebook, Twitter, and Instagram for updates on upcoming meetings, such as CJKSRS 2024, iSRS 2025, and membership perks, such as job opportunities!
